Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

755797

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Respiratory System: Medicine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much the NHS has spent on respiratory medicines in each of the last five years.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	7167
answer	answer is ministerial correction date of answer 11/09/2017 answer text <p>The information requested is shown in the table below.</p><p> </p><p>Cost of respiratory medicines to the National Health Service, by primary and secondary care, in England from years 2012 to 2016</p><table><tbody><tr><td><p> </p></td><td><p>Primary Care Net Ingredient Cost (£)</p></td><td><p>Secondary Care Cost (£)</p></td><td><p>Total Cost (£)</p></td></tr><tr><td><p>2012</p></td><td><p>1,009,505,840</p></td><td><p>39,842,049</p></td><td><p>1,049,347,889</p></td></tr><tr><td><p>2013</p></td><td><p>1,020,038,047</p></td><td><p>39,938,913</p></td><td><p>1,059,976,960</p></td></tr><tr><td><p>2014</p></td><td><p>1,032,783,044</p></td><td><p>38,983,420</p></td><td><p>1,071,766,464</p></td></tr><tr><td><p>2015</p></td><td><p>1,044,951,211</p></td><td><p>38,600,943</p></td><td><p>1,083,552,154</p></td></tr><tr><td><p>2016</p></td><td><p>1,034,877,082</p></td><td><p>38,547,801</p></td><td><p>1,073,424,883</p></td></tr></tbody></table><p>Source: Prescription Cost Analysis; 2016 QuintilesIMS: Hospital Pharmacy Audit Index</p><p> </p><p>These figures do not include costs for treating respiratory infections or cancers, as the medicines required (antibiotics and chemotherapy) are used for other therapy areas and are not specific to respiratory disease. These costs are at list prices and discounts achieved by hospitals and community pharmacy have not been included.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/09/2017 16:00:35 answering member 4067 label Biography information for Steve Brine
tabling member	151 label Biography information for Tom Brake

755799

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps are being taken to improve definitions of myalgic encephalomyelitis for diagnosis.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	7179
answer	answer is ministerial correction date of answer 11/09/2017 answer text <p>Information on the exact number of patients receiving treatment for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is not collected. The National Institute for Health and Care Excellence (NICE) clinical guideline, ‘Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children estimates that the annual prevalence is approximately 4,000 cases per million of the population.</p><p>The NICE clinical guideline set outs best practice for clinicians on the diagnosis, treatment, care and support of people with the condition and supports commissioners to to plan services for local populations. NICE routinely reviews its guidance to ensure it reflects the latest available evidence, including international evidence. In spring 2017, NICE reviewed the CFS/ME guideline to assess whether new research on CCFS/ME would impact on the current guideline recommendations. This included looking at new evidence concerning diagnostic criteria. Having assessed the evidence, NICE published its provisional recommendation not to update the NICE guideline for consultation on 10 July for a period of two weeks. NICE’s final recommendation is expected in October 2017.</p><p> </p><p>In terms of training, the General Medical Council sets out the knowledge, skills and behaviours that new United Kingdom medical graduates must be able to demonstrate and Royal Medical Colleges, such as the Royal College of General Practitioners (RCGP) set the standards for postgraduate medical education in general practice. General practice is where most patients with CFS/ME are likely to be managed, and the condition is identified as a key area of clinical knowledge in the RCGP Applied Knowledge Test (AKT) content guide. The AKT is a summative assessment of the knowledge base that underpins general practice in the UK within the context of the National Health Service and is a key part of general practitioner’s (GPs) qualifying exams.</p><p> </p><p>Once fully qualified, clinicians are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance, such as that produced by NICE.</p><p>The Department has made no assessment has been made of guidelines on CFS/ME published by health authorities in Canada and other countries.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 7180 7181 7593 7594 7595 question first answered 11/09/2017 16:08:57 answering member 4067 label Biography information for Steve Brine
tabling member	1566 label Biography information for Daniel Kawczynski

755800

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what training is provided for doctors to help them treat patients with myalgic encephalomyelitis.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	7180
answer	answer is ministerial correction date of answer 11/09/2017 answer text <p>Information on the exact number of patients receiving treatment for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is not collected. The National Institute for Health and Care Excellence (NICE) clinical guideline, ‘Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children estimates that the annual prevalence is approximately 4,000 cases per million of the population.</p><p>The NICE clinical guideline set outs best practice for clinicians on the diagnosis, treatment, care and support of people with the condition and supports commissioners to to plan services for local populations. NICE routinely reviews its guidance to ensure it reflects the latest available evidence, including international evidence. In spring 2017, NICE reviewed the CFS/ME guideline to assess whether new research on CCFS/ME would impact on the current guideline recommendations. This included looking at new evidence concerning diagnostic criteria. Having assessed the evidence, NICE published its provisional recommendation not to update the NICE guideline for consultation on 10 July for a period of two weeks. NICE’s final recommendation is expected in October 2017.</p><p> </p><p>In terms of training, the General Medical Council sets out the knowledge, skills and behaviours that new United Kingdom medical graduates must be able to demonstrate and Royal Medical Colleges, such as the Royal College of General Practitioners (RCGP) set the standards for postgraduate medical education in general practice. General practice is where most patients with CFS/ME are likely to be managed, and the condition is identified as a key area of clinical knowledge in the RCGP Applied Knowledge Test (AKT) content guide. The AKT is a summative assessment of the knowledge base that underpins general practice in the UK within the context of the National Health Service and is a key part of general practitioner’s (GPs) qualifying exams.</p><p> </p><p>Once fully qualified, clinicians are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance, such as that produced by NICE.</p><p>The Department has made no assessment has been made of guidelines on CFS/ME published by health authorities in Canada and other countries.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 7179 7181 7593 7594 7595 question first answered 11/09/2017 16:08:57 answering member 4067 label Biography information for Steve Brine
tabling member	1566 label Biography information for Daniel Kawczynski

755801

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many patients received NHS treatment for myalgic encephalomyelitis in the last 12 months.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	7181
answer	answer is ministerial correction date of answer 11/09/2017 answer text <p>Information on the exact number of patients receiving treatment for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is not collected. The National Institute for Health and Care Excellence (NICE) clinical guideline, ‘Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children estimates that the annual prevalence is approximately 4,000 cases per million of the population.</p><p>The NICE clinical guideline set outs best practice for clinicians on the diagnosis, treatment, care and support of people with the condition and supports commissioners to to plan services for local populations. NICE routinely reviews its guidance to ensure it reflects the latest available evidence, including international evidence. In spring 2017, NICE reviewed the CFS/ME guideline to assess whether new research on CCFS/ME would impact on the current guideline recommendations. This included looking at new evidence concerning diagnostic criteria. Having assessed the evidence, NICE published its provisional recommendation not to update the NICE guideline for consultation on 10 July for a period of two weeks. NICE’s final recommendation is expected in October 2017.</p><p> </p><p>In terms of training, the General Medical Council sets out the knowledge, skills and behaviours that new United Kingdom medical graduates must be able to demonstrate and Royal Medical Colleges, such as the Royal College of General Practitioners (RCGP) set the standards for postgraduate medical education in general practice. General practice is where most patients with CFS/ME are likely to be managed, and the condition is identified as a key area of clinical knowledge in the RCGP Applied Knowledge Test (AKT) content guide. The AKT is a summative assessment of the knowledge base that underpins general practice in the UK within the context of the National Health Service and is a key part of general practitioner’s (GPs) qualifying exams.</p><p> </p><p>Once fully qualified, clinicians are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance, such as that produced by NICE.</p><p>The Department has made no assessment has been made of guidelines on CFS/ME published by health authorities in Canada and other countries.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 7179 7180 7593 7594 7595 question first answered 11/09/2017 16:08:57 answering member 4067 label Biography information for Steve Brine
tabling member	1566 label Biography information for Daniel Kawczynski

755808

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Multiple Sclerosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many patients the NHS is treating for multiple sclerosis.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	7178
answer	answer is ministerial correction date of answer 08/09/2017 answer text <p>This information is not available. The National Institute for Health and Care Excellence estimates that multiple sclerosis affects around 100,000 people in the United Kingdom.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/09/2017 11:40:53 answering member 4067 label Biography information for Steve Brine
tabling member	1566 label Biography information for Daniel Kawczynski

755811

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the rate of complete immunisation is for children under the age of four.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	7130
answer	answer is ministerial correction date of answer 11/09/2017 answer text <p>Public Health England reports information on the rate of complete immunisation for children at 12 months, 24 months and at five years. The most recently published report is the Quarterly vaccination coverage statistics for children aged up to five years in the United Kingdom (COVER programme): January to March 2017 which can be accessed here:</p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/623860/hpr2317_COVER.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/623860/hpr2317_COVER.pdf</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/09/2017 15:52:10 answering member 4067 label Biography information for Steve Brine
tabling member	478 label Biography information for Lord Field of Birkenhead

755817

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: North East
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans his Department has for a specialist drug treatment and recovery pilot programme in the North East.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	7238
answer	answer is ministerial correction date of answer 12/09/2017 answer text <p>Local authorities are responsible for commissioning effective drug and alcohol prevention and treatment services based on an assessment of local need. Public Health England (PHE) supports local authorities to do this, by providing bespoke data, value for money tools, topical briefings, and advice on good practice to help local authorities meet the needs of their local population. In the North East, PHE work to help local areas prevent drug-related deaths includes:</p><p> </p><p>- running forums and networks to facilitate regional groups of commissioners, providers and service users working together, sharing practice and disseminating new policy and guidance;</p><p>- offering bespoke support packages to local authorities where necessary; and</p><p>- promoting the use of naloxone and training people how to use it across the North East.</p><p>Nationally, PHE has issued advice on providing naloxone, published updated clinical guidelines for drug treatment and worked with a network of treatment providers to establish good practice guidance on managing drug-related death risk factors and to improve partnership between treatment providers and other healthcare services.</p><p>PHE has also established a new Public Health Outcomes Framework indicator on drug-related deaths to enable local areas benchmark their performance against others.</p><p> </p><p>Ongoing national work by PHE to help prevent drug-related deaths includes:</p><p> </p><p>- helping local authorities improve their drug-related death review process;</p><p>- helping local authorities increase the number of people with drug problems who are in drug treatment; and</p><p>- improving intelligence on the adverse health effects of drugs.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 7218 7468 question first answered 12/09/2017 16:29:46 answering member 4067 label Biography information for Steve Brine
tabling member	3973 label Biography information for Grahame Morris

755820

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: North East
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the latest statistical bulletin published by the Office for National Statistics on deaths related to drug poisoning, what steps he is taking to address the disproportionately high drug mortality rate in the North East.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	7218
answer	answer is ministerial correction date of answer 12/09/2017 answer text <p>Local authorities are responsible for commissioning effective drug and alcohol prevention and treatment services based on an assessment of local need. Public Health England (PHE) supports local authorities to do this, by providing bespoke data, value for money tools, topical briefings, and advice on good practice to help local authorities meet the needs of their local population. In the North East, PHE work to help local areas prevent drug-related deaths includes:</p><p> </p><p>- running forums and networks to facilitate regional groups of commissioners, providers and service users working together, sharing practice and disseminating new policy and guidance;</p><p>- offering bespoke support packages to local authorities where necessary; and</p><p>- promoting the use of naloxone and training people how to use it across the North East.</p><p>Nationally, PHE has issued advice on providing naloxone, published updated clinical guidelines for drug treatment and worked with a network of treatment providers to establish good practice guidance on managing drug-related death risk factors and to improve partnership between treatment providers and other healthcare services.</p><p>PHE has also established a new Public Health Outcomes Framework indicator on drug-related deaths to enable local areas benchmark their performance against others.</p><p> </p><p>Ongoing national work by PHE to help prevent drug-related deaths includes:</p><p> </p><p>- helping local authorities improve their drug-related death review process;</p><p>- helping local authorities increase the number of people with drug problems who are in drug treatment; and</p><p>- improving intelligence on the adverse health effects of drugs.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 7238 7468 question first answered 12/09/2017 16:29:45 answering member 4067 label Biography information for Steve Brine
tabling member	3973 label Biography information for Grahame Morris

754711

registered interest
date	20/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Smoking
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans he has to fund tobacco cessation services during this Parliament.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	6510
answer	answer is ministerial correction date of answer 08/09/2017 answer text <p>Smoking cessation services are a key part of the Government’s tobacco control strategy which is outlined in the recently published tobacco control plan. Councils will receive £16 billion of public health funding between 2016 and 2021 to provide vital services for their local population including smoking cessation services. Funding plans beyond 2021 will be the subject of a new Spending Review.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/09/2017 14:52:07 answering member 4067 label Biography information for Steve Brine
tabling member	1521 label Biography information for Mrs Sharon Hodgson

754712

registered interest
date	20/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Running
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what information his Department holds on how many British running clubs have organised Couch to 5K programme since the inception of that programme.
tabling member constituency	Blaenau Gwent
tabling member printed	Nick Smith
uin	6486
answer	answer is ministerial correction date of answer 06/09/2017 answer text <p>In 2016, Public Health England (PHE) launched a mobile app in partnership with British Broadcasting Corporation (BBC) Get Inspired, based on NHS Choices’ Couch to 5K web site. The method of evaluating the effect and value for money of the Couch to 5K app in England involves tracking the number of downloads and conducting qualitative research.</p><p> </p><p>The app has received more than 500,000 downloads since launch<sup>1</sup>. The feedback from users is positive with many referencing the voice-over from popular coaches being especially motivating.</p><p> </p><p>The app does not record mobile sensor data and there is no historical app data available to compare pre and post usage.</p><p> </p><p>The app has been especially designed for people who have done little or no running. We hold no information on the activities of running clubs in relation to the Couch to 5K programme.</p><p><sup>1</sup> Source: Google Analytics</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 6692 6831 question first answered 06/09/2017 13:06:58 answering member 4067 label Biography information for Steve Brine
tabling member	3928 label Biography information for Nick Smith